These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Development of single-agent chemotherapy regimens for gestational trophoblastic disease. Homesley HD J Reprod Med; 1994 Mar; 39(3):185-92. PubMed ID: 7518517 [TBL] [Abstract][Full Text] [Related]
3. [Effects of primary chemotherapy with single methotrexate on low-risk gestational trophoblastic neoplasia and influencing factors thereof]. Chen YX; Shen YM; Qian JH; Xie X Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(30):2109-12. PubMed ID: 16313819 [TBL] [Abstract][Full Text] [Related]
4. Methotrexate infusion and folinic acid as primary therapy for nonmetastatic and low-risk metastatic gestational trophoblastic tumors. 15 years of experience. Garrett AP; Garner EO; Goldstein DP; Berkowitz RS J Reprod Med; 2002 May; 47(5):355-62. PubMed ID: 12063874 [TBL] [Abstract][Full Text] [Related]
6. Medium-dose methrotrexate/folinic acid regimen in the chemotherapy of gestational trophoblastic disease. Khoo SK; Jones IS Med J Aust; 1980 Apr; 1(7):317-20. PubMed ID: 6248746 [TBL] [Abstract][Full Text] [Related]
9. Weekly methotrexate (50mg/m(2)) without dose escalation as a primary regimen for low-risk gestational trophoblastic neoplasia. Kang WD; Choi HS; Kim SM Gynecol Oncol; 2010 Jun; 117(3):477-80. PubMed ID: 20347479 [TBL] [Abstract][Full Text] [Related]
10. Low-risk persistent gestational trophoblastic disease: outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000. McNeish IA; Strickland S; Holden L; Rustin GJ; Foskett M; Seckl MJ; Newlands ES J Clin Oncol; 2002 Apr; 20(7):1838-44. PubMed ID: 11919242 [TBL] [Abstract][Full Text] [Related]
11. [Single methotrexate chemotherapy for low-risk gestational trophoblastic tumor]. Lu WG; Ding ZM; Xie X; Ye DF; Chen HZ; Feng SW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Aug; 25(4):414-7. PubMed ID: 12974085 [TBL] [Abstract][Full Text] [Related]
12. Low-risk gestational trophoblastic neoplasia and methotrexate resistance: predictors of response to treatment with actinomycin D and need for combination chemotherapy. Growdon WB; Wolfberg AJ; Goldstein DP; Feltmate CM; Chinchilla ME; Lieberman ES; Berkowitz RS J Reprod Med; 2010; 55(7-8):279-84. PubMed ID: 20795339 [TBL] [Abstract][Full Text] [Related]
15. Early identification of resistance to first-line single-agent methotrexate in patients with persistent trophoblastic disease. van Trommel NE; Massuger LF; Schijf CP; ten Kate-Booij MJ; Sweep FC; Thomas CM J Clin Oncol; 2006 Jan; 24(1):52-8. PubMed ID: 16382113 [TBL] [Abstract][Full Text] [Related]
16. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia. Lybol C; Sweep FC; Harvey R; Mitchell H; Short D; Thomas CM; Ottevanger PB; Savage PM; Massuger LF; Seckl MJ Gynecol Oncol; 2012 Jun; 125(3):576-9. PubMed ID: 22410329 [TBL] [Abstract][Full Text] [Related]
17. Single-dose methotrexate regimen in the treatment of low-risk gestational trophoblastic neoplasia. Chan KK; Huang Y; Tam KF; Tse KY; Ngan HY Am J Obstet Gynecol; 2006 Nov; 195(5):1282-6. PubMed ID: 16723109 [TBL] [Abstract][Full Text] [Related]
18. 30 years' experience in the treatment of low-risk gestational trophoblastic neoplasia in Hungary. Fülöp V; Szigetvári I; Szepesi J; Végh G; Bátorfi J; Nagymányoki Z; Török M; Berkowitz RS J Reprod Med; 2010; 55(5-6):253-7. PubMed ID: 20626182 [TBL] [Abstract][Full Text] [Related]
19. Single-dose methotrexate for the treatment of unruptured ectopic pregnancy. Erdem M; Erdem A; Arslan M; Oç A; Biberoğlu K; Gürsoy R Arch Gynecol Obstet; 2004 Dec; 270(4):201-4. PubMed ID: 12955534 [TBL] [Abstract][Full Text] [Related]